ADGC Publications

Found 7 results
Filters: Author is Schellenberg, Gerard D and Keyword is Apolipoprotein E4  [Clear All Filters]
2022
Rajabli F, Beecham GW, Hendrie HC, Baiyewu O, Ogunniyi A, Gao S, Kushch NA, Lipkin-Vasquez M, Hamilton-Nelson KL, Young JI et al..  2022.  A locus at 19q13.31 significantly reduces the ApoE ε4 risk for Alzheimer's Disease in African Ancestry.. PLoS Genet. 18(7):e1009977.
Jun GR, You Y, Zhu C, Meng G, Chung J, Panitch R, Hu J, Xia W, Bennett DA, Foroud TM et al..  2022.  Protein phosphatase 2A and complement component 4 are linked to the protective effect of APOE ɛ2 for Alzheimer's disease.. Alzheimers Dement. 18(11):2042-2054.
2018
Rajabli F, Feliciano BE, Celis K, Hamilton-Nelson KL, Whitehead PL, Adams LD, Bussies PL, Manrique CP, Rodriguez A, Rodriguez V et al..  2018.  Ancestral origin of ApoE ε4 Alzheimer disease risk in Puerto Rican and African American populations.. PLoS Genet. 14(12):e1007791.
2014
Borenstein AR, Wu Y, Bowen JD, McCormick WC, Uomoto J, McCurry SM, Schellenberg GD, Larson EB.  2014.  Incidence rates of dementia, Alzheimer disease, and vascular dementia in the Japanese American population in Seattle, WA: the Kame Project.. Alzheimer Dis Assoc Disord. 28(1):23-9.
2013
Tsuang D, Leverenz JB, Lopez OL, Hamilton RL, Bennett DA, Schneider JA, Buchman AS, Larson EB, Crane PK, Kaye JA et al..  2013.  APOE ε4 increases risk for dementia in pure synucleinopathies.. JAMA Neurol. 70(2):223-8.
2010
Li G, Shofer JB, Rhew IC, Kukull WA, Peskind ER, McCormick W, Bowen JD, Schellenberg GD, Crane PK, Breitner JCS et al..  2010.  Age-varying association between statin use and incident Alzheimer's disease.. J Am Geriatr Soc. 58(7):1311-7.
Borenstein AR, Mortimer JA, Schellenberg GD, DeCarli C, Copenhaver C, Galasko D, Salmon DP, Petersen R.  2010.  Effects of apolipoprotein E-epsilon4 and -epsilon2 in amnestic mild cognitive impairment and dementia in Shanghai: SCOBHI-P.. Am J Alzheimers Dis Other Demen. 25(3):233-8.